help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on January 18, 2005, doi:10.1164/rccm.200501-037OC

Am. J. Respir. Crit. Care Med., Volume 171, Number 7, April 2005, 728-733

A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200501-037OCv1
200501-037OCv2
171/7/728    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laghi, F.
Right arrow Articles by Tobin, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laghi, F.
Right arrow Articles by Tobin, M. J

Submitted on April 13, 2004
Accepted on January 7, 2005

Hypogonadism in Men with Chronic Obstructive Pulmonary Disease: Prevalence and Quality of Life

Franco Laghi1, Andreea Antonescu-Turcu1, Eileen Collins1, Jeremy Segal1, Damien E Tobin1, Amal Jubran1, and Martin J Tobin1*

1 Division of Pulmonary and Critical Care Medicine, Edward Hines Jr. Veterans Administration Hospital, Hines, IL, USA; Loyola University of Chicago, Stritch School of Medicine, Hines, IL, USA

* To whom correspondence should be addressed. E-mail: mtobin2{at}lumc.edu.

We recently reported that hypogonadism does not affect respiratory muscle performance and exercise capacity in men with chronic obstructive pulmonary disease. In chronic obstructive pulmonary disease, however, the relationship between exercise capacity and quality of life is controversial, making it unreliable to extrapolate about quality of life from exercise data. Accordingly, we determined prevalence and impact of hypogonadism on health-related quality of life in men with chronic obstructive pulmonary disease. We enrolled 101 stable outpatient men (forced expiratory volume in one second, 1.34±0.04 liter) over 55 years; 38 patients were hypogonadal - a prevalence similar to that reported in the general population. The degree of airflow limitation did not predict levels of free testosterone. Quality of life, as quantified by a disease-specific instrument (St. George Respiratory Questionnaire) and general-health instrument (Veterans Short Form-36) were equivalent in the hypogonadal and eugonadal groups. Both groups demonstrated large decrements in perceived physical health and smaller decrements in perceived emotional and mental health. No relationship was found between free-testosterone level and physical activity, respiratory symptoms or quality of life. In conclusion, hypogonadism, although common among men over 55 with chronic obstructive pulmonary disease, does not worsen the severity of respiratory symptoms or quality of life.


Key words: testosterone, androgens, exercise tolerance, aging, health status




This article has been cited by other articles:


Home page
Eur Respir JHome page
F. Laghi, N. Adiguzel, and M. J. Tobin
Endocrinological derangements in COPD
Eur. Respir. J., October 1, 2009; 34(4): 975 - 996.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. I. Lewis, M. Fournier, T. W. Storer, S. Bhasin, J. Porszasz, S.-G. Ren, X. Da, and R. Casaburi
Skeletal muscle adaptations to testosterone and resistance training in men with COPD
J Appl Physiol, October 1, 2007; 103(4): 1299 - 1310.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. L. Ries, G. S. Bauldoff, B. W. Carlin, R. Casaburi, C. F. Emery, D. A. Mahler, B. Make, C. L. Rochester, R. ZuWallack, and C. Herrerias
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
Chest, May 1, 2007; 131(5_suppl): 4S - 42S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Laghi
Low Testosterone in Chronic Obstructive Pulmonary Disease: Does It Really Matter?
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1069 - 1070.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer
Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1105 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  New Orleans Int'l Conf